ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in ImageneBio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- +4 vs. Q4 2023
- Shares held
- 30.1M
- −2.29M (−7.1%) vs. Q4 2023
- Total value
- $42.7M
- −$21.1M (−33.0%) vs. Q4 2023
- New holders
- 12
- 15 more added
- Sold out
- 8
- 17 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 3 | $0 | 0.00% | +3 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 3 | $4 | 0.00% | +3 | New |
| Farther Finance Advisors, LLC | 35 | $49 | 0.00% | +35 | New |
| Royal Bank of Canada | 707 | $1.00K | 0.00% | −10,204−93.5% | Reduced |
| Amalgamated Bank | 717 | $1.00K | 0.00% | −1,138−61.3% | Reduced |
| Ameritas Investment Partners, Inc. | 1,755 | $2.49K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 2,045 | $2.90K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 3,515 | $4.99K | 0.00% | −1,580−31.0% | Reduced |
| FMR LLC | 5,801 | $8.24K | 0.00% | −4,178,492−99.9% | Reduced |
| Citigroup Inc | 5,804 | $8.24K | 0.00% | +1,173+25.3% | Added |
| Tower Research Capital LLC (TRC) | 8,928 | $12.7K | 0.00% | +3,933+78.7% | Added |
| Atom Investors LP | 10,155 | $14.4K | 0.00% | +10,155 | New |
| Invesco Ltd. | 10,158 | $14.4K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,880 | $15.4K | 0.00% | +1,404+14.8% | Added |
| SG Americas Securities, LLC | 12,490 | $18.0K | 0.00% | −7,732−38.2% | Reduced |
| JPMorgan Chase & Co | 13,341 | $18.9K | 0.00% | −8,988−40.3% | Reduced |
| Ensign Peak Advisors, Inc | 13,794 | $19.6K | 0.00% | −76,516−84.7% | Reduced |
| New York State Common Retirement Fund | 14,992 | $21.3K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 15,255 | $21.7K | 0.00% | −131−0.9% | Reduced |
| Prudential Financial Inc | 16,920 | $24.0K | 0.00% | +16,920 | New |
| Bank of America Corp | 19,226 | $27.3K | 0.00% | −30,756−61.5% | Reduced |
| Rhumbline Advisers | 27,813 | $39.5K | 0.00% | +900+3.3% | Added |
| UBS Group AG | 32,749 | $46.5K | 0.00% | +11,659+55.3% | Added |
| ADAR1 Capital Management, LLC | 35,000 | $49.7K | 0.01% | +35,000 | New |
| XTX Topco Ltd | 35,272 | $50.1K | 0.01% | +35,272 | New |
| Cornercap Investment Counsel Inc | 36,157 | $51.3K | 0.01% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 36,322 | $51.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 38,621 | $54.8K | 0.00% | −120.0% | Reduced |
| Morgan Stanley | 49,440 | $70.2K | 0.00% | −19,137−27.9% | Reduced |
| Bank of New York Mellon Corp | 70,940 | $100.7K | 0.00% | +1,701+2.5% | Added |
| Goldman Sachs Group Inc | 72,597 | $103.1K | 0.00% | +49,002+207.7% | Added |
| Marquette Asset Management, LLC | 72,890 | $103.5K | 0.02% | +72,890 | New |
| Two Sigma Advisers, LP | 79,900 | $113.5K | 0.00% | +79,900 | New |
| Bridgeway Capital Management, LLC | 82,300 | $116.9K | 0.00% | −61,250−42.7% | Reduced |
| Charles Schwab Investment Management Inc | 85,946 | $122.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 88,691 | $125.9K | 0.00% | +88,691 | New |
| Citadel Advisors LLC | 159,015 | $225.8K | 0.00% | −19,162−10.8% | Reduced |
| Barclays PLC | 196,820 | $279.5K | 0.00% | −47,835−19.6% | Reduced |
| Northern Trust Corp | 234,269 | $332.7K | 0.00% | −4,303−1.8% | Reduced |
| Two Sigma Investments, LP | 242,960 | $345.0K | 0.00% | +192,027+377.0% | Added |
| Acadian Asset Management LLC | 282,782 | $400.0K | 0.00% | +261,060+1,201.8% | Added |
| Adage Capital Partners GP, L.L.C. | 287,900 | $408.8K | 0.00% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 382,616 | $543.3K | 0.03% | +19,137+5.3% | Added |
| Acuitas Investments, LLC | 397,746 | $564.8K | 0.28% | +397,746 | New |
| State Street Corp | 482,645 | $685.4K | 0.00% | +71,900+17.5% | Added |
| Jacobs Levy Equity Management, Inc | 513,440 | $729.1K | 0.00% | +457,245+813.7% | Added |
| NEA Management Company, LLC | 570,050 | $809.5K | 0.05% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 597,277 | $848.2K | 0.00% | +67,908+12.8% | Added |
| Renaissance Technologies LLC | 776,600 | $1.10M | 0.00% | +776,600 | New |
| Verition Fund Management LLC | 1,134,687 | $1.61M | 0.02% | −187,710−14.2% | Reduced |
| Vanguard Group Inc | 1,532,169 | $2.18M | 0.00% | +7,321+0.5% | Added |
| BlackRock Inc. | 1,828,752 | $2.60M | 0.00% | −29,404−1.6% | Reduced |
| Omega Fund Management, LLC | 2,249,123 | $3.19M | 2.06% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,539,358 | $5.03M | 0.10% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,891,118 | $5.53M | 1.10% | +1,937,502+99.2% | Added |
| BVF Inc | 4,769,164 | $6.77M | 0.19% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $7.13M | 0.66% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −999,513−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −372,613−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −322,671−100.0% | Sold out |
| Vida Ventures Advisors, LLC | 0 | $0 | 0.00% | −225,192−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −209,315−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,882−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −22,072−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,170−100.0% | Sold out |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |